You are here

lixisenatide

Parkinson’s disease may be helped by GLP-1 drug, new study finds

Stat

Wed, 04/3/24 - 10:41 pm

Parkinson's Disease

Sanofi Wins FDA Panel’s Backing for Once-Daily Diabetes Combo

Bloomberg

Wed, 05/25/16 - 09:35 pm

advisory panels

Sanofi takes an FDA shortcut with its diabetes combo, racing with Novo

Fierce Biotech

Wed, 12/23/15 - 09:34 pm

Sanofi Gains on New Drug Application

Bidness, ETC

Wed, 12/23/15 - 11:13 am

insulin glargine

Sanofi test shows lixisenatide doesn't increase cardiovascular risk

Yahoo/Reuters

Thu, 03/19/15 - 11:07 am

Odd Move By Sanofi On Diabetes Drug Application

Yahoo/YCharts

Mon, 09/16/13 - 10:06 am

Lixisenatide NDA Withdrawn by Sanofi

Yahoo/Zacks

Sat, 09/14/13 - 10:52 am

type 2 diabetes

Sanofi Pulls U.S. File for Lixisenatide Diabetes Drug

Bloomberg

Thu, 09/12/13 - 08:00 am

Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes

Yahoo/PR NewsWire

Sun, 06/23/13 - 11:28 am

type 2 diabetes

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

Yahoo

Tue, 02/19/13 - 09:54 am

Zealand Pharma Announces GetGoal Duo 1 and GetGoal-L Phase III Data on Lixisenatide (Lyxumia(R))1 to be Presented at ADA

Yahoo/Global NewsWire

Sun, 06/10/12 - 11:14 am

type 2 diabetes

Lyxumia(R) (lixisenatide) in Combination With Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose

Yahoo/MarketWire

Sun, 06/10/12 - 11:12 am

type 2 diabetes

Sanofi Diabetes Drug Worked as Well as Byetta in Study

Bloomberg

Wed, 02/2/11 - 08:42 am

Sanofi Lixisenatide Diabetes Treatment Had Significant Phase Three Results

Bloomberg

Thu, 09/30/10 - 09:47 am

It'll Be a Blockbuster! High Fives All Around, Right?

Motley Fool

Sat, 04/17/10 - 12:36 pm

drug development

Sanofi-Aventis diabetes drug meets study endpoints

Marketwatch

Thu, 04/15/10 - 08:43 am